TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04984304

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle modifications and Antireflux diet
Description: Patients in Arm 1 - mild cough only slightly worsening the quality of life (VAS 1-3) will undergo treatment using lifestyle modifications and an Antireflux diet for 3 months.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Extraesophageal reflux diagnostic
Description: Patients in Arm 2 - moderate and severe cough that significantly worsen the quality of life (VAS 4-10) will undergo extraesophageal reflux diagnostics consisting of esophageal 24-hour pH/Impedance Reflux Monitoring and peptest study on fasting
Study: NCT06285019

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TOMOX-HAIC
Description: Oxaliplatin 85mg/m\^2 plus Raltitrexed 3mg/m\^2, 21 days for a cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: 200mg, ivgtt, d1, 21 days for a cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 7.5mg/kg, ivgtt, d1, 21 days for a cycle
Study: NCT04747691

Intervention type: DIAGNOSTIC_TEST
Intervention: Bedside gastric ultrasound
Description: Bedside ultrasound exam of the stomach
Study: NCT05711459

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bicyclol tablets
Description: Take Bicyclol tablets for the treatment of liver injury.
Study: NCT05423665

Intervention type: OTHER
Intervention: sample collection
Description: blood sample at 21 weeks of gestation clips of the fetal heart at 21 weeks of gestation, 30 weeks of gestation and 1-3 days after birth collection of umbilical cord blood at birth collection of the placenta at birth

Intervention type: OTHER
Intervention: sample collection
Description: blood sample at 21 weeks of gestation clips of the fetal heart at 21 weeks of gestation, 30 weeks of gestation and 1-3 days after birth collection of umbilical cord blood at birth collection of the placenta at birth
Study: NCT06725329

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A tailored psychosocial education intervention
Description: Participants will get ten 60-minute psychoeducational group sessions about chronic pain and its management. The group sessions will be conducted by the PI and a bilingual project director at Korean churches or daycare centers in Baltimore-Washington Metropolitan area.~The psychoeducational group session will be adapted from LAMP intervention that has been previously developed. The intervention provides biopsychosocial education sessions about chronic pain and its management. For example, sessions focus on providing information regarding: (1) pain and the biological stress response and the gate control theory of pain, (2) the psychological impact of thoughts and emotions on pain and (3) facilitated group discussions to help participants develop a new understanding of pain through shared social experiences, all of which have been shown to improve pain outcomes.
Study: NCT05688696

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Orelabrutinib (Low Dose)
Description: Subjects will be administered with lower dose of Orelabrutinib orally once daily in combination with SOC therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Orelabrutinib (High Dose)
Description: Subjects will be administered with higher dose of Orelabrutinib orally once daily in combination with SOC therapy

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Orelabrutinib Placebo
Description: Subjects will be administered with Orelabrutinib Placebo orally once daily in combination with SOC therapy
Study: NCT06508463

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo tumor biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo tumor biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo SPECT/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo SPECT/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET scan

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter
Description: Given IV
Study: NCT04749901

Intervention type: OTHER
Group type: OTHER
Intervention: Psycho-emotional and semiological measures
Description: Surveys, interviews and measures

Intervention type: OTHER
Group type: OTHER
Intervention: Psycho-emotional and semiological measures
Description: Surveys, interviews and measures

Intervention type: OTHER
Group type: OTHER
Intervention: Psycho-emotional and semiological measures
Description: Surveys, interviews and measures

Intervention type: OTHER
Group type: OTHER
Intervention: Psycho-emotional and semiological measures
Description: Surveys, interviews and measures
Study: NCT05783011

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Description: Electroacupuncture was applied bilaterally to the LI4, ST5 and ST6 acupuncture points before and after periodontal flap surgery

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: periodontal flap surgery
Description: periodontal flap surgery

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: periodontal flap surgery
Description: periodontal flap surgery
Study: NCT05710367

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10mg Tab
Description: Forxiga® as an add-on treatment in patients with renal and/or cardiac association FD in an exploratory framework.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matched oral drug. Placebo tablet will have the same color, taste, smell and package as the verum tablet
Study: NCT05200975

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Venapunction
Description: Three venapunctures within a period of 72 hours, containing a maximum of 18ml of venous blood in total.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Venapunction
Description: Three venapunctures within a period of 72 hours, containing a maximum of 18ml of venous blood in total.
Study: NCT05671042

Intervention type: OTHER
Intervention: Patients with Upper excretory tract tumors
Description: Standard of care for patients with Sezary Syndrome
Study: NCT06191562

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tympanostomy tube
Description: Participants will receive an ear tube in the usual location (anterior-inferior) in one ear and a new location (posterior-inferior) in the other ear during surgery.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tympanostomy tube
Description: Participants will receive an ear tube in the usual location (anterior-inferior) in one ear and a new location (posterior-inferior) in the other ear during surgery.
Study: NCT05784467

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Methamphetamine, PrEP, and Intersectional Stigma (eMPrISe) study
Description: Group behavioral intervention with 12 weekly sessions lasting 2 hours focusing on coping, resistance, and resilience.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Methamphetamine, PrEP, and Intersectional Stigma (eMPrISe) study
Description: Group behavioral intervention with 12 weekly sessions lasting 2 hours focusing on coping, resistance, and resilience.
Study: NCT06377449

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasound examination of the lungs
Description: Experimental: Standard ultrasound examination of the lungs based on modified BLUE protocol Active Comparator: Standard ultrasound examination of the lungs based on modified BLUE protocol

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound examination of the lungs
Description: Experimental: Standard ultrasound examination of the lungs based on modified BLUE protocol Active Comparator: Standard ultrasound examination of the lungs based on modified BLUE protocol
Study: NCT06629038

Intervention type: BEHAVIORAL
Intervention: observation alone
Description: observation of maximal mouth opening, lateral excursion, and range of motion of shoulder abduction, neck joint

Intervention type: BEHAVIORAL
Intervention: observation alone
Description: observation of maximal mouth opening, lateral excursion, and range of motion of shoulder abduction, neck joint
Study: NCT06715904

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Womens with Morton´s Extension
Description: Morton extension application

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Womens with Morton´s Extension
Description: Morton extension application
Study: NCT06722443

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Probiotic
Description: Treatment with capsules with 10\^9 CFU/ day of Limosilactobacillus fermentum CECT5716 during 6 months

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic
Description: Treatment with capsules with 10\^9 CFU/ day of Limosilactobacillus fermentum CECT5716 during 6 months

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic
Description: Treatment with capsules with 10\^9 CFU/ day of Limosilactobacillus fermentum CECT5716 during 6 months

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Prebiotic
Description: Treatment with capsules 500 mg/capsule/day of olive leaf extract, containing 35% oleuropein during 6 months

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Prebiotic
Description: Treatment with capsules 500 mg/capsule/day of olive leaf extract, containing 35% oleuropein during 6 months

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Prebiotic
Description: Treatment with capsules 500 mg/capsule/day of olive leaf extract, containing 35% oleuropein during 6 months

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Synbiotic
Description: A pill with a combination of prebiotic and probiotic at the same doses during 6 months

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Synbiotic
Description: A pill with a combination of prebiotic and probiotic at the same doses during 6 months

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Synbiotic
Description: A pill with a combination of prebiotic and probiotic at the same doses during 6 months
Study: NCT06717256

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: training
Description: The diabetes education booklet is a collection of information designed by the researcher. These interventions will continue for 1.5 months, with a total of 6 sessions for each type 2 DM individual, lasting approximately 120 minutes (2 hours per week and 12 hours in total after 6 weeks), and will be carried out as reminders afterwards. In these sessions, agendas will be created appropriately on regular eating habits, physical activity, regular monitoring of blood sugar, compliance with treatment, problem-solving ability, coping strategies and minimizing risks, conflicts regarding self-management and skin care behaviors of the patient will be tried to be resolved, the patient's suitability and adaptation to the change phase will be determined, their willingness to change will be questioned, and the change plan will be helped in the matters of care and self-management.
Study: NCT06724406

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Quantity: 5
Description: The number of family skills training sessions administered: 5 sessions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Quantity: 5
Description: The number of family skills training sessions administered: 5 sessions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Quantity: 5
Description: The number of family skills training sessions administered: 5 sessions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Quantity: 5
Description: The number of family skills training sessions administered: 5 sessions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Quantity: 5
Description: The number of family skills training sessions administered: 5 sessions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Quantity: 5
Description: The number of family skills training sessions administered: 5 sessions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Quantity: 5
Description: The number of family skills training sessions administered: 5 sessions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Quantity: 5
Description: The number of family skills training sessions administered: 5 sessions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Mode: In-person
Description: The mode of administration of family skills training sessions: in person or online

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Mode: In-person
Description: The mode of administration of family skills training sessions: in person or online

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Mode: In-person
Description: The mode of administration of family skills training sessions: in person or online

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Mode: In-person
Description: The mode of administration of family skills training sessions: in person or online

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Mode: In-person
Description: The mode of administration of family skills training sessions: in person or online

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Mode: In-person
Description: The mode of administration of family skills training sessions: in person or online
Study: NCT06508463

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single Photon Emission Computed Tomography
Description: Undergo SPECT/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single Photon Emission Computed Tomography
Description: Undergo SPECT/CT

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Given IV
Study: NCT06508463

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Given IV
Study: NCT06040944

Intervention type: DRUG
Intervention: antipsychotic drugs inducing hyperprolactinemia
Description: not exposed
Study: NCT06724406

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Quantity: 10
Description: The number of family skills training sessions administered: 10 sessions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Quantity: 10
Description: The number of family skills training sessions administered: 10 sessions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Mode: Online
Description: The mode of administration of family skills training sessions: online

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Mode: Online
Description: The mode of administration of family skills training sessions: online

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Mode: Online
Description: The mode of administration of family skills training sessions: online

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Session Mode: Online
Description: The mode of administration of family skills training sessions: online
Study: NCT00908804

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: open appendectomy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: laparoscopic appendectomy
Study: NCT06413979

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Support Protocol for Adolescent Internalizing Disorders (Fam-AID)
Description: (1) Family Engagement of caregivers and primary supports in treatment planning and services; (2) Relational Reframing of family constraints, resiliencies, and social capital connected to the youth's ID symptoms; (3) Functional Analysis of the youth's ID symptoms and related behaviors; (4) Cognitive-behavioral therapy (CBT) core techniques to address the youth's ID symptoms and functional needs, featuring three transdiagnostic interventions (emotion acceptance, emotional exposure, behavioral activation) to address negative affect and emotional dysregulation underlying both depression and anxiety; and (5) Family Psychoeducation and Safety Planning focused on education about comorbid SUD/ID and prevention of youth self-harm. All interventions featured in each module have strong empirical support.
Study: NCT06267534

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: mindfulness-based mobile applications program
Description: Every two days is the same practice sound file, which must be practiced in order, so each sound file will be locked, for example: 9/9, 9/10 listen to the first sound file practice, 9/11, 9/12 listen to the second Practice with two sound files... and so on. After two days, the sound files will be automatically unlocked, and the subjects can continue to practice. The first ten days need to be practiced in order. From the eleventh day, each sound file will be unlocked. You can choose an audio file to practice, and the page will record the time and items of the practice, and you can also use text to record your experience after the practice
Study: NCT04955886

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Surufatinib(HMPL-012)
Description: Surufatinib(250mg) will be orally administered within 1 hour after breakfast once a day (QD) , Toripalimab was administered intravenously at a fixed dose of 240 mg, and the infusion time was 60 ± 5 min, once every 21 days. The cumulative longest medication period is 2 years. Until disease progression, death, intolerable toxicity or other protocol specified end-of-treatment criteria is met .
Study: NCT06724406

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Content: No Cohesion
Description: The content of family skills training sessions administered focused on cohesion: no cohesion

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Skills Training Content: No Cohesion
Description: The content of family skills training sessions administered focused on cohesion: no cohesion
Study: NCT06723600

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Information
Description: Nurse-led family member information
Study: NCT06723080

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VC005 low dose group
Description: VC005 low dose group repeat administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VC005 high dose group
Description: VC005 high dose group repeat administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: VC005 Placebo group
Description: VC005 Placebo group repeat administration
Study: NCT06724874

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Web-Based Deep Relaxation Exercise
Description: Web-based deep relaxation exercise videos have been prepared online. Each video lasts approximately 20-25 minutes. The 4-week applications will be sent to pregnant women one video each week and they will be asked to continue the exercises at home 4 times a week.
Study: NCT06722937

Intervention type: OTHER
Intervention: Observation
Description: Observe the clinical natural changes of eye parameters of the subjects.

Intervention type: OTHER
Intervention: Observation
Description: Observe the clinical natural changes of eye parameters of the subjects.

Intervention type: OTHER
Intervention: Observation
Description: Observe the clinical natural changes of eye parameters of the subjects.

Intervention type: OTHER
Intervention: Observation
Description: Observe the clinical natural changes of eye parameters of the subjects.
Study: NCT06482541

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: 5 billion exosomes and saline solution microneedling
Description: Participants will receive 5 billion WJMSC-exosome topical application on one half of the treatment area and an equivalent volume of saline solution on the contralateral half of the treatment area. Microneedling at a depth of .5mm on the entire treatment area will immediately follow the exosome and saline application. Participants will also receive 4 permanent microdot tattoos on the aforementioned locations.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: 50 billion exosomes and saline solution microneedling
Description: Participants will receive 50 billion WJMSC-exosome topical application on one half of the treatment area and an equivalent volume of saline solution on the contralateral half of the treatment area. Microneedling at a depth of .5mm on the entire treatment area will immediately follow the exosome and saline application. Participants will also receive 4 permanent microdot tattoos on the aforementioned locations.